Vertex Pharmaceuticals Inc. (VRTX) News
Filter VRTX News Items
VRTX News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
VRTX News Highlights
- VRTX's 30 day story count now stands at 23.
- Over the past 25 days, the trend for VRTX's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- AMP, LI and GENE are the most mentioned tickers in articles about VRTX.
Latest VRTX News From Around the Web
Below are the latest news stories about VERTEX PHARMACEUTICALS INC that investors may wish to consider to help them evaluate VRTX as an investment opportunity.
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No TomorrowWith a new medicine on the market and plenty of money, Vertex is in great shape. |
3 Monster Stocks to Buy Without Any HesitationThese are easy choices for investors seeking market-beating long-term gains. |
Should You Invest in Bluebird Bio Right Now?After two December share price crashes, there's no evident cure for Bluebird Bio's ills. |
3 Top Stocks to Buy Hand Over Fist Before the End of 2023These are ideal stocks to buy sooner rather than later. |
Editas Just Caught a Break Thanks to Vertex PharmaceuticalsEditas isn't out of the woods yet, but it's better off than before. |
5 Top Stocks to Buy With Your End-of-the-Year BonusYour bonus could become the gift that keeps on giving. |
Could CRISPR Therapeutics Stock Help You Become a Millionaire?There are plenty of reasons to be optimistic about CRISPR's future. |
Could Sarepta Therapeutics Be the Next Vertex Pharmaceuticals Stock?Both develop medicines for rare diseases, and each aims to conquer a niche market. |
Up More Than 60% in 2023, Is It Too Late to Buy This Soaring Biotech Stock?The FDA's recent approval of CRISPR Therapeutics' first therapy is a step in the right direction. |
3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone’It's now time to take a look at these three biotech stocks to buy, as each one is currently within TradeSmith's "Green Zone." |